For the year ending 2025-12-31, CRDF has $61,884K in assets. $16,496K in debts. $17,470K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 17,470 | |||
| Short-term investments | 40,834 | |||
| Accounts receivable and unbilled receivable | 182 | |||
| Prepaid expenses and other current assets | 1,642 | |||
| Total current assets | 60,128 | |||
| Property and equipment, net | 578 | |||
| Operating lease right-of-use assets | 629 | |||
| Other assets | 549 | |||
| Total assets | 61,884 | |||
| Accounts payable | 8,087 | |||
| Accrued liabilities | 7,577 | |||
| Operating lease liabilities | 730 | |||
| Total current liabilities | 16,394 | |||
| Operating lease liabilities, net of current portion | 102 | |||
| Total liabilities | 16,496 | |||
| Common stock, 0.0001 par value, 150,000 shares authorized 68,305 and 66,524 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 7 | |||
| Additional paid-in capital | 475,361 | |||
| Accumulated other comprehensive gain | 50 | |||
| Accumulated deficit | -430,030 | |||
| Total stockholders equity | 45,388 | |||
| Total liabilities and stockholders equity | 61,884 | |||
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)